Sal Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-05-2024
- Paid Up Capital ₹ 0.30 M
as on 19-05-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
About Sal Biosciences
The Corporate was formerly known as Sal Agrotech Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Hanumanthaiah, Sumanth Muralidhar, Muralidhar Vasista, and Two other members serve as directors at the Company.
- CIN/LLPIN
U01100KA2019PTC119942
- Company No.
119942
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sal Biosciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Hanumanthaiah  | Additional Director | 16-Feb-2024 | Current |
| Sumanth Muralidhar | Director | 02-Jan-2019 | Current |
| Muralidhar Vasista | Director | 02-Jan-2019 | Current |
| Bangalore Ashiq | Additional Director | 16-Feb-2024 | Current |
| Venkatesh Ramaswamy | Additional Director | 16-Feb-2024 | Current |
Financial Performance of Sal Biosciences.
Sal Biosciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sal Biosciences?
Unlock access to Sal Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Zeinix Labs India Private LimitedActive 5 years 3 monthsSumanth Muralidhar and Muralidhar Vasista are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sal Biosciences?
Unlock and access historical data on people associated with Sal Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sal Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sal Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.